Efficacy as measured by median time to hospital discharge (Part 2);Safety and Tolerability of ANA001 as measured by the incidence of treatment emergent adverse events (TEAE's) (Part 1 and Part 2)

Efficacy as measured by median time to hospital discharge (Part 2);Safety and Tolerability of ANA001 as measured by the incidence of treatment emergent adverse events (TEAE's) (Part 1 and Part 2)